Literature DB >> 22205711

Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy.

Bhagu R Bhavnani1, Frank Z Stanczyk.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22205711     DOI： 10.1210/jc.2011-2492

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

2.  Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes.

Authors:  V Calabrese; G Scapagnini; S Davinelli; G Koverech; A Koverech; C De Pasquale; A Trovato Salinaro; M Scuto; E J Calabrese; A R Genazzani
Journal:  J Cell Commun Signal       Date:  2014-11-09       Impact factor: 5.782

3.  Bioidentical hormone therapy: Nova Scotia pharmacists' knowledge and beliefs.

Authors:  Anne Marie Whelan; Jean-Pierre Thebeau; Tannis M Jurgens; Eileen Hurst
Journal:  Pharm Pract (Granada)       Date:  2012-09-30

4.  Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy.

Authors:  James H Pickar; Charles Bon; Julia M Amadio; Sebastian Mirkin; Brian Bernick
Journal:  Menopause       Date:  2015-12       Impact factor: 2.953

5.  Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies.

Authors:  Frank Z Stanczyk; Chunying Niu; Colleen Azen; Sebastian Mirkin; Julia M Amadio
Journal:  Menopause       Date:  2019-09       Impact factor: 2.953

6.  Cardiovascular Changes in Menopause.

Authors:  Anjana R Nair; Aiswarya J Pillai; Nandini Nair
Journal:  Curr Cardiol Rev       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.